FLU-SHIELD Vaccine Trial

Study Overview

A pivotal study evaluating a next-generation influenza vaccine designed to provide broader protection against multiple flu strains. The study will assess immunogenicity and safety in healthy adults.

Inclusion Criteria

• ✓Adults aged 18-65 years
• ✓Generally good health
• ✓No flu vaccination in past 6 months
• ✓Available for all scheduled visits

Exclusion Criteria

• ✗Immunocompromised individuals
• ✗Allergy to vaccine components
• ✗Fever within past 72 hours
• ✗History of Guillain-Barré syndrome